CJC-1295 / Ipamorelin research guide
A factual reference for laboratories working with CJC-1295 / Ipamorelin: what the material is, how it is handled and stored, how to read its certificate of analysis, and how to order it in Canada. It is written for in-vitro research and makes no claims about effects in people or animals.
What is CJC-1295 / Ipamorelin?
This product is a mixture of two distinct peptides supplied in one vial, 5mg of each. CJC-1295 is a synthetic 30-residue analogue of the first 29 residues of growth hormone releasing hormone (GHRH), extended by one lysine. It carries four amino acid substitutions relative to natural GRF(1-29), including D-alanine at position 2, and its C-terminal lysine carries a maleimidopropionyl group. That reactive group allows the peptide to form a covalent bond with thiols such as the free cysteine of serum albumin, which is the property the compound was designed to study.
Ipamorelin is a synthetic pentapeptide, Aib-His-D-2-Nal-D-Phe-Lys-NH2. Three of its five residues, aminoisobutyric acid, D-2-naphthylalanine and D-phenylalanine, are not among the twenty standard amino acids. It is a growth hormone secretagogue receptor (GHS-R1a) ligand and is unrelated in sequence to CJC-1295.
Synergy Research supplies the mixture as a lyophilised solid in a sealed glass vial. Both peptides are produced by solid-phase synthesis and combined before lyophilisation. A three-vial set adds MOTS-c alongside this mixture.
Specification summary
Values are taken from the product page and the public PubChem record. Each lot is confirmed against them by the independent testing reported on the certificate of analysis.
Research context
CJC-1295 is studied in receptor-binding and cAMP assays at the GHRH receptor and in albumin-conjugation chemistry, where the maleimide reaction with cysteine-34 of albumin is followed by mass spectrometry. Ipamorelin is studied at the ghrelin receptor, GHS-R1a, usually in calcium-mobilisation or radioligand-binding assays using cells expressing that receptor.
Because the two peptides act at different receptors, laboratories working with the mixture usually need to account for both in their assay design. Neither peptide is an approved drug, and both are listed as prohibited by the World Anti-Doping Agency.
Synergy Research does not evaluate, summarise or endorse the findings of any study. The material is supplied so that laboratories can design and run their own in-vitro experiments.
Storage and handling for laboratory use
Unopened vials of CJC-1295 / Ipamorelin should be stored sealed, in a cool, dry place away from light. Refrigeration at 2 to 8 °C is used for longer storage, and freezing at -20 °C is common practice for lyophilised material held for many months. The lyophilised solid is far more stable than any solution, so vials should remain unopened until they are needed.
The maleimide group on CJC-1295 is reactive towards thiols and slowly hydrolyses in water. Keep the solid dry and reconstitute only shortly before use. Ipamorelin, with its non-standard residues, is comparatively stable.
Allow a cold vial to reach room temperature before removing the cap or piercing the stopper, so that moisture from the air does not condense on the solid. Record the lot number from the label in your laboratory notebook; it is the link between the vial and its certificate.
Reconstitution in the laboratory
Lyophilised material is dissolved immediately before use in a sterile diluent appropriate to the assay. Bacteriostatic water (0.9% benzyl alcohol), sterile water for laboratory use, or a neutral buffer such as phosphate-buffered saline are common choices. The diluent is added slowly down the inside wall of the vial rather than directly onto the powder, and the vial is swirled or rolled gently until the solid dissolves.
The mixture dissolves in sterile water with gentle swirling. Avoid thiol-containing additives such as dithiothreitol or mercaptoethanol unless conjugation is the intended reaction, because they will react with the maleimide on CJC-1295.
The volume of diluent determines the concentration of the resulting solution; laboratories calculate it from the stated vial content and the molar mass given above. Solutions should be labelled with compound, concentration, lot number and date, kept refrigerated and protected from light, and discarded according to your own stability data. Repeated freeze-thaw cycles should be avoided; if a solution must be stored frozen, divide it into single-use aliquots first.
How to read the Certificate of Analysis
Every lot Synergy Research sells is tested by an independent Canadian laboratory, and the resulting certificate is published on the Certificates of Analysis page. A certificate has three parts worth checking before you use a vial.
- Identity. Mass spectrometry measures the molecular mass of the material and compares it with the theoretical value. For a two-component product the certificate reports two HPLC peaks and two mass spectrometry identities: one consistent with 3647.2 g/mol for CJC-1295 and one with 711.9 g/mol for Ipamorelin. Purity may be stated per component.
- Purity. Reversed-phase HPLC with UV detection separates the main compound from related impurities. The area of the main peak as a percentage of total peak area is reported as purity. Look for the chromatogram itself, not only the number.
- Traceability. The lot number on the certificate should match the number printed on your vial, and the certificate should name the testing laboratory and the date of analysis.
If a certificate for your lot is not yet posted, email [email protected] with the lot number and it will be sent when the laboratory report is in.
Frequently asked questions
What is in the vial?
5mg of CJC-1295 and 5mg of Ipamorelin, combined and lyophilised together. The two peptides act at different receptors.
What does "DAC" mean in relation to CJC-1295?
DAC stands for drug affinity complex and refers to the maleimidopropionyl group on the C-terminal lysine that reacts with albumin thiols. The CJC-1295 in this product carries that group.
Can the two peptides be separated?
Not practically in a laboratory setting. If you need either compound alone, note that Synergy Research lists them together; check the compound list for current single-peptide availability.
How is a mixture tested on the COA?
The independent laboratory runs HPLC, which separates the two peptides into distinct peaks, and mass spectrometry to confirm each identity. Both results appear on the certificate for the lot.
Is this mixture for human or animal use?
No. It is supplied for in-vitro laboratory research only.
Buy CJC-1295 / Ipamorelin in Canada
Synergy Research supplies CJC-1295 / Ipamorelin as a 5mg / 5mg vial. Orders ship across Canada by Canada Post Xpresspost with tracking, and payment is accepted by Interac e-Transfer or card. Every vial is matched to a published certificate of analysis.
View CJC-1295 / Ipamorelin product page →See also: how to choose a research peptide supplier in Canada and the certificate archive.
For Research Use Only. Not for human or animal consumption, and not for use in diagnostic or therapeutic procedures. Nothing on this page describes, recommends or implies any use of this material in people or animals. See our Research Use Policy.